BSL-3 Laboratory (High-containment)
In response to the needs of domestic academic research institutions and biotechnology companies, our Biosafety Level 3 (BSL-3) laboratory of ID Core is responsible for the development of required assays and performs studies of emerging infectious diseases. We provide the research collaboration, commissioned research and/or technical service for both academia and biotechnology industries, targeting on pre-clinical cell-based efficacy examination, virulence, pathogenesis studies, as well as immunological bridging analyses.
🎯 Research positioning
Focus on the research and technical services of Risk Group 3 (RG3) agents
Focus on critical infectious diseases that affect public health, including but not only on the following pathogens:
• High-pathogenic influenza (HPAI) virus, such as H5N1, H7N9 virus
• SARS-CoV-2
• Monkeypox virus
• Other ONE Health (Human-Animal-Environment) associated common zoonotic or human pathogens
🧪 Scope of services
• Provide collaborative/commissioned research and technical services to support domestic academia, research institutions, and the biotech industry product development
• Perform the diagnostics and cell-based anti-RG3 agents assays, such as Rapid test, disinfectant functional tests.
• Support preclinical testing and efficacy evaluation of new drugs, antibodies, and vaccines, such as neutralization test, HI assay…etc.
• Conduct validation analysis of reagents and products related to the prevention and control of infectious diseases.
🚀 Accelerating domestic bioindustry development
Conduct the commissioned research/services, to accelerate the translation of outstanding biomedical research findings into viable products, and to support the development of domestic biotechnology industry.
🛡️ Epidemic prevention role
In response to domestic or global epidemics/pandemic, we will also be part of national epidemic prevention system, and endeavored to provide strong technical supports on prevention and control of infectious diseases.
Team
The Infectious Disease Core facility (ID Core) has experienced microbiology and immunology research team that is responsible for the management and conduct of experimental studies of infectious research in the BSL-3 laboratories. We provide collaborative/commissioned research and technical services of infectious disease.
Commissioned research/service items (ID Core BSL-3 laboratory):
- Development and testing of microbial diagnostic reagents
- Drug screening and efficacy test
- Research and development of the vaccines of emerging infectious diseases, and Immuno-bridging analyses post-vaccination/post-infection:
- Blood CBC and blood biochemical analyses
- Cellular immunity (T cells)
- Humoral immunity (B cells)
- Multiplex Cytokine/Chemokine analysis
- Development of disinfectant and efficacy evaluation
- Customized collaborative or commissioned services targeting on the development of vaccines, drugs, or device testing
Contact us
Facility Director: Dr. Wen-Chun Liu, Tel: 886-2-7750-5815
Email: wenchun0617@as.edu.tw
• Commissioned research/services
Contact: Dr. Yi-An Ko, Tel: 886-2-7750-5857
Email: koyian@as.edu.tw
Contact information for website correction: Ms. Wu Tel: (02) 7750-5500#2579 E-mail:kiswu2003@as.edu.tw
